Mark Grady

635 total citations
8 papers, 308 citations indexed

About

Mark Grady is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Grady has authored 8 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Grady's work include Inhalation and Respiratory Drug Delivery (4 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Hemodynamic Monitoring and Therapy (2 papers). Mark Grady is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Hemodynamic Monitoring and Therapy (2 papers). Mark Grady collaborates with scholars based in United States. Mark Grady's co-authors include Michael A. Matthay, T. Sakuma, Randolph H. Hastings, Mark R. Holland, Joshua Murphy, Philip T. Levy, Gautam K. Singh, Aaron Hamvas, Meghna D. Patel and Swati Choudhry and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and Neurology.

In The Last Decade

Mark Grady

8 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Grady United States	6	230	112	61	60	39	8	308
Juan Calvo Spain	9	166 0.7×	40 0.4×	35 0.6×	76 1.3×	30 0.8×	27	259
Soshi Hashimoto Japan	11	214 0.9×	44 0.4×	73 1.2×	44 0.7×	42 1.1×	14	368
C.-F. Wippermann Germany	10	101 0.4×	133 1.2×	114 1.9×	96 1.6×	52 1.3×	17	331
S. Rezaiguia France	7	228 1.0×	57 0.5×	76 1.2×	36 0.6×	89 2.3×	9	369
Sharon Howell United States	11	122 0.5×	155 1.4×	67 1.1×	289 4.8×	31 0.8×	21	381
Nathane Santanna Felix Brazil	10	218 0.9×	38 0.3×	37 0.6×	19 0.3×	47 1.2×	17	326
P D Ridley United Kingdom	11	179 0.8×	38 0.3×	189 3.1×	108 1.8×	61 1.6×	21	361
Ashley Sullivan United States	6	55 0.2×	130 1.2×	112 1.8×	102 1.7×	52 1.3×	9	321
W B Knight United Kingdom	10	228 1.0×	128 1.1×	101 1.7×	86 1.4×	10 0.3×	18	305
C Döhlemann Germany	10	148 0.6×	104 0.9×	91 1.5×	163 2.7×	48 1.2×	30	372

Countries citing papers authored by Mark Grady

Since Specialization

Citations

This map shows the geographic impact of Mark Grady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Grady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Grady more than expected).

Fields of papers citing papers by Mark Grady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Grady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Grady. The network helps show where Mark Grady may publish in the future.

Co-authorship network of co-authors of Mark Grady

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Grady. A scholar is included among the top collaborators of Mark Grady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Grady. Mark Grady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Grady, Mark, et al.. (2024). Subacute Inflammatory Demyelinating Polyneuropathy (SIDP) Secondary to Tumor Necrosis Factor (TNF)-Alpha Inhibitor (Adalimumab) for the Treatment of Rheumatoid Arthritis: A Case Report (P4-14.019). Neurology. 102(7_supplement_1). 6854–6854. 1 indexed citations

2.

Levy, Philip T., Meghna D. Patel, Swati Choudhry, et al.. (2016). Pulmonary Artery Acceleration Time Provides a Reliable Estimate of Invasive Pulmonary Hemodynamics in Children. PMC. 3 indexed citations

3.

Levy, Philip T., Meghna D. Patel, Swati Choudhry, et al.. (2016). Pulmonary Artery Acceleration Time Provides a Reliable Estimate of Invasive Pulmonary Hemodynamics in Children. Journal of the American Society of Echocardiography. 29(11). 1056–1065. 138 indexed citations

4.

Bharat, Ankit, Deirdre J. Epstein, Mark Grady, et al.. (2013). Lung transplant is a viable treatment option for patients with congenital and acquired pulmonary vein stenosis. The Journal of Heart and Lung Transplantation. 32(6). 621–625. 15 indexed citations

5.

Pittet, Jean‐François, Michael A. Matthay, Gerald B. Pier, Mark Grady, & J. P. Wiener-Kronish. (1993). Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody.. Journal of Clinical Investigation. 92(3). 1221–1228. 22 indexed citations

6.

Hastings, Randolph H., Mark Grady, T. Sakuma, & Michael A. Matthay. (1992). Clearance of different-sized proteins from the alveolar space in humans and rabbits. Journal of Applied Physiology. 73(4). 1310–1316. 67 indexed citations

7.

Arakawa, Masaaki, et al.. (1990). Effects of dextran 70 on hemodynamics and lung liquid and protein exchange in awake sheep.. Circulation Research. 67(4). 852–861. 7 indexed citations

8.

Berthiaume, Yves, Kurt H. Albertine, Mark Grady, Gordon H. Fick, & Michael A. Matthay. (1989). Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h. Journal of Applied Physiology. 67(5). 1887–1897. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact